naphthalimides has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conti, L; Dallanoce, C; De Amici, M; Del Bufalo, D; Guerriero, C; Matera, C; Tata, AM | 1 |
| Buckner, JC; Burch, PA; Cascino, TL; Gallagher, JG; Goldberg, RM; Levitt, R; Morton, RF; O'Fallon, JR; Scheithauer, BW; Westberg, MW | 1 |
1 trial(s) available for naphthalimides and Brain Neoplasms
| Article | Year |
|---|---|
Phase II study of amonafide in patients with recurrent glioma.
Topics: Adenine; Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Nervous System Diseases; Oligodendroglioma; Organophosphonates; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 1995 |
1 other study(ies) available for naphthalimides and Brain Neoplasms
| Article | Year |
|---|---|
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Muscarinic Agonists; Naphthalimides; Neoplastic Stem Cells; Receptor, Muscarinic M2; Signal Transduction; Temozolomide | 2021 |